Benson J Edagwa

10PUBLICATIONS
28CO-AUTHORS
Medical devicesGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPowder and particle technologyAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tail.

Mohammad Ullah Nayan, Brady Sillman, Srijanee Das

|Aug 01, 2025
A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression.

Samiksha S Raut, Srijanee Das, Grace Bybee

|Mar 04, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic Tail.

Benson Edagwa, Mohammad Ullah Nayan, Brady Sillman

|Dec 23, 2022
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression.

Srijanee Das, Weimin Wang, Murali Ganesan

|Jun 10, 2022
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.

Suyash Deodhar, Brady Sillman, Aditya N Bade

|Jun 06, 2022
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases.

Vicente Soriano, Benson Edagwa, Carmen de Mendoza

Pageof 2

Frequent Collaborators

10 joint publications

Howard Gendelman

6 joint publications

Samuel M Cohen

4 joint publications

Brady Sillman

4 joint publications

Srijanee Das